-
October 10, 2008
Arimidex® Not Associated with Cognitive Impairment Among Postmenopausal Women at High Risk for Breast Cancer
Researchers from the United Kingdom have reported that the use of the aromatase inhibitor Arimidex® (anastrozole) does not appear to be associated with cognitive impairment among postmenopausal women at a high risk of developing breast cancer. These results were recently published in the October, 2008 issue of Lancet Oncology.
-
October 10, 2008
United States Preventive Task Force Provides Recommendations for Colorectal Cancer Screening
The United States Preventive Services Task Force (USPSTF) has recently issued recommendations for the screening of colorectal cancer. These recommendations were published in the Archives of Internal Medicine.
-
October 10, 2008
Nexavar® May Overcome Resistance to Arimidex® in Breast Cancer
Researchers from Georgetown University have reported that the addition of Nexavar® (sorafenib) to Arimidex® (anastrozole) helps restore sensitivity to Arimidex among women with breast cancer. These results were recently presented at the 2008 annual American Society of Clinical Oncology (ASCO) breast cancer symposium.
-
October 10, 2008
NSAIDs May Reduce Risk of Breast Cancer
The use of non-steroidal anti-inflammatory drugs (NSAIDS), including both aspirin and ibuprofen, appears to significantly reduce the risk of developing breast cancer. These results were recently published in the Journal of the National Cancer Institute.
-
October 9, 2008
Quarter of adolescent U.S. girls received HPV
WASHINGTON (Reuters) - A quarter of girls aged 13 to 17 in the United States received Merck & Co's Gardasil vaccine last year to protect against the human papillomavirus, which causes cervical cancer, the U.S. government said on Thursday.
-
October 9, 2008
Risk of Colon Cancer Associated with Genetic Variants
Researchers from several medical centers have reported that genetic changes in the surrounding region of the ADIPQ gene are associated with a decrease in the risk of developing colorectal cancer. Results such as these may aid in the understanding of genetic risk of various cancers, ultimately changing the way in which cancer is managed. These results were recently published in the October 1, 2008 issue of the Journal of the American Medical Association.
-
October 9, 2008
Red wine may ward off lung cancer: study
NEW YORK (Reuters Health) - Drinking red wine, but not white wine, may reduce lung cancer risk, especially among current and ex-smokers, new research indicates.
-
October 9, 2008
Allogeneic Stem Cell Transplantation Effective for Elderly with AML
Researchers affiliated with the Cooperative German Transplant Group have reported that unrelated donor stem cell transplants result in similar outcomes to related donor transplants in patients over the age of 50 years with acute myeloid leukemia (AML). The details of this study appeared in an early online publication in the Journal of Clinical Oncology on September 2, 2008.
-
October 9, 2008
Bone fracture ups risk of male breast cancer
NEW YORK (Reuters Health) - While rare, breast cancer can occur in men and a new study suggests that the risk of developing male breast cancer is increased by having a close relative with breast cancer, being obese and physically inactive, and "somewhat surprisingly," suffering a bone fracture after the age of 45.
-
October 9, 2008
Some depressed patients opt for assisted suicide
NEW YORK (Reuters Health) - The results of a survey in Oregon suggest that the Death with Dignity Act enacted in the state in 1997 does not always prevent patients with depression, a treatable condition, from receiving a prescription for a lethal drug.
-
October 9, 2008
Scripps to study lifestyle impact of gene testing
LOS ANGELES (Reuters) - San Diego's Scripps Translational Science Institute said on Thursday it will conduct the first study to assess whether people undergoing genetic testing ultimately change their behavior.
-
October 8, 2008
Guidelines Published for the Treatment of Acute Promyelocytic Leukemia
Researchers affiliated with the European LeukemiaNet have published guidelines for the management of acute promyelocytic leukemia (APL). These guidelines were published in an early online manuscript in Blood on September 23, 2008.
-
October 8, 2008
Risk of Colon Cancer Associated with Genetic Variants
Genetic changes in the surrounding region of the ADIPQ gene are associated with a decrease in the risk of developing colorectal cancer. Results such as these may aid in the understanding of genetic risk of various cancers, ultimately changing the way in which cancer is managed. These results were recently published in the Journal of the American Medical Association.
-
October 8, 2008
Nexavar® May Overcome Resistance to Arimidex® in Breast Cancer
The addition of Nexavar® (sorafenib) to Arimidex® (anastrozole) helps restore sensitivity to Arimidex among women with breast cancer. These results were recently presented at the 2008 annual American Society of Clinical Oncology (ASCO) breast cancer symposium.
-
October 8, 2008
Single Reading with Computer-aided Detection Equivalent to Double Reading of Mammograms
Researchers from the United Kingdom have reported, “Single reading with computer-aided detection could be an alternative to double reading and could also improve the rate of detection of cancer from screening mammograms read by a single reader.” The details of this study appeared in an early online publication in the New England Journal of Medicine on October 1, 2008.
-
October 7, 2008
Campath® and Rituxan® Promising for Untreated High-risk CLL
Researchers from the Mayo Clinic have reported that early treatment of asymptomatic patients with high-risk features of chronic lymphocytic leukemia (CLL) with Campath® (alemtuzumab) and Rituxan® (rituximab) appears promising. The details of this study appeared in the October 15, 2008 issue of Cancer.
-
October 7, 2008
Long-term Incense Use Increases Risk of Cancer Upper Respiratory Tract Cancer
Researchers from Singapore have reported that long-term incense use increases the risk of squamous cell carcinoma of the respiratory tract. The details of this study appeared in the October 1, 2008 issue of Cancer.
-
October 7, 2008
Vitamin D deficiency makes bowel disease worse
NEW YORK (Reuters Health) - A vitamin D deficiency can make inflammatory bowel disease more severe and worsen the quality of life for affected individuals, according to a study presented this week at the 73rd annual scientific meeting of the American College of Gastroenterology.
-
October 7, 2008
End-of-life talk has cascading benefits: study
NEW YORK (Reuters Health) - In terminally ill patients, "end-of-life" discussions with their doctor do not increase emotional distress or reduce quality of life, a study shows. On the contrary, these discussions improve the quality of life of both the patient and loved ones when death is near.
-
October 7, 2008
Arimidex® Not Associated with Cognitive Impairment Among Postmenopausal Women at High Risk for Breast Cancer
The use of the aromatase inhibitor Arimidex® (anastrozole) does not appear to be associated with cognitive impairment among postmenopausal women at a high risk of developing breast cancer. These results were recently published in the Lancet Oncology.
-
October 7, 2008
Single Reading with Computer-aided Detection Equivalent to Double Reading of Mammograms
The results of a study recently published in the New England Journal of Medicine indicate that using computer-aided detection (computer programs that identify suspicious areas on mammograms) along with a single reader of mammograms could be an alternative to using double readers and could also improve the cancer detection rate from mammograms that are read by a single reader.
-
October 6, 2008
Nobel medicine prize reopens old AIDS dispute
WASHINGTON (Reuters) - The decision announced Monday to award the Nobel Prize for Medicine to Luc Montagnier and Francoise Barre-Sinoussi for their discovery of the AIDS virus was perceived by many to be a snub to U.S. virologist Dr. Robert Gallo, and reopened an old dispute over the research.
-
October 6, 2008
Late Mortality Persists Beyond Five Years in Children with Cancer
Researchers affiliated with the Children’s Oncology Group have reported that children with cancer who survive five years still remain at risk and need continued observation. The details of this study appeared in an early online publication in the Journal of the National Cancer Institute on September 23, 2008.
-
October 6, 2008
Addition of Avastin® to Tarceva® Does Not Appear to Improve Survival in Patients with Advanced Non–Small Cell Lung Cancer
According to the results of a Phase III clinical trial, treatment with Avastin® (bevacizumab) plus Tarceva® (erlotinib) did not result in better survival than treatment with Tarceva alone among patients with advanced non–small cell lung cancer (NSCLC) whose disease had progressed following platinum-based chemotherapy. These results were recently published in a press release by Genentech.
-
October 6, 2008
Possible Link between Hepatitis B Virus and Pancreatic Cancer
Researchers from the M. D. Anderson Cancer Center in Texas have reported that exposure to the hepatitis B virus may be associated with the development of pancreatic cancer. The study was recently published in the October 1, 2008 issue of the Journal of Clinical Oncology.
-
October 6, 2008
Drug combo doesn't boost lung cancer survival
ZURICH/LONDON (Reuters) - Roche Holding AG and Genentech Inc said on Monday a study of the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.
-
October 6, 2008
AIDS pioneers and cancer researcher win Nobel prize
STOCKHOLM (Reuters) - Two French scientists who discovered the AIDS virus and a German who found the virus that causes cervical cancer were awarded the 2008 Nobel prize for medicine or physiology on Monday.
-
October 4, 2008
Proteins in Saliva May Detect Oral Cancer
Researchers from the University of California at Los Angeles have reported that proteins detected from saliva may be effective in identifying the presence of oral cancer. These results were recently published in Clinical Cancer Research.
-
October 4, 2008
Hormone Therapy May Not Increase Risk of Breast Cancer in Postmenopausal Women with a BRCA1 Mutation
Researchers affiliated with the Hereditary Breast Cancer Clinical Study Group have reported that hormone therapy for postmenopausal women with a BRCA1 mutation does not appear to increase the risk of breast cancer. The details of this study appeared in the October 1, 2008 issue of the Journal of the National Cancer Institute.
-
October 3, 2008
Diabetes not linked with prostate cancer death
NEW YORK (Reuters Health) - Obesity, rather than diabetes, increases the risk that men being treated for locally advanced prostate cancer will die from the cancer, researchers report.
-
October 3, 2008
Genetic tests may pinpoint who should get Avastin
LONDON (Reuters) - Genetic tests could in future show who will respond best to Genentech and Roche's blockbuster cancer drug Avastin - a positive development for patients but not necessarily for sales.
-
October 3, 2008
Diamond-studded drug patch may help in
CHICAGO (Reuters) - A new drug patch material studded with tiny specks of diamonds may one day allow cancer patients to get chemotherapy just where they need it, U.S. researchers said on Thursday.
-
October 3, 2008
Proteins in Saliva May Detect Oral Cancer
Proteins that can be detected within saliva may be effective in identifying the presence of oral cancer. These results were recently published in Clinical Cancer Research.
-
October 3, 2008
Long sick leave for colds signals poor health later - study
LONDON (Reuters) - Employees off sick for long periods - even for common conditions like flu - are far more likely to die before their co-workers who do not take such leave, researchers said on Friday.
-
October 2, 2008
Possible Link between Hepatitis B Virus and Pancreatic Cancer
The results of a recent study at M.D. Anderson Cancer Center in Texas indicate that exposure to the Hepatitis B virus may be associated with the development of pancreatic cancer. The study was recently published in the Journal of Clinical Oncology.
-
October 2, 2008
Nighttime urination may lower bladder cancer risk
NEW YORK (Reuters Health) - There may be an up side to having to "go" during the night. People who wake up at night to urinate are less likely to develop bladder cancer, an international research team has found.
-
October 2, 2008
Intensive Hyper-CVAD Regimen for Older Patients with ALL Effective
Researchers from M. D. Anderson Cancer Center have reported that hyper-CVAD (hypofractionated Cytoxan® [cyclophosphamide], Oncovin® [vincristine], Adrimycin® [doxorubicin], and dexamethasone) alternated with high doses of methotrexate and Cytosar® (cytarabine) improves the complete remission rate and survival in elderly patients with acute lymphoblastic leukemia (ALL). The details of this study appeared in an early online publication of Cancer on August 20, 2008.
-
October 2, 2008
Hormone Therapy May Not Increase Risk of Breast Cancer in Postmenopausal Women with a BRCA1 Mutation
According to the results of a recent study published in the Journal of the National Cancer Institute, hormone therapy for postmenopausal women with a BRCA1 mutation does not appear to increase the risk of breast cancer.
-
October 2, 2008
Study Suggests No Difference in Outcomes for Open Versus Robotic Surgery for Prostate Cancer
Researchers from the Mayo Clinic have reported that laparoscopic robotic prostatectomy (LRP) had similar outcomes to open retropubic prostatectomy. The details of this study appeared in an early online publication in the British Journal of Urology International on September 5, 2008.
-
October 2, 2008
Hypnosis eases post-breast cancer hot flashes
NEW YORK (Reuters Health) - Hypnosis can help reduce hot flashes among breast cancer survivors, new research published in the Journal of Clinical Oncology shows.
-
October 1, 2008
Computer aid improves reading of mammograms
NEW YORK (Reuters Health) - In evaluating mammograms for breast cancer, a single reader with computer assistance can perform just as well as two readers, researchers have found.
-
October 1, 2008
Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme
For the first time ever, the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors has issued treatment guidelines for patients with newly diagnosed glioblastoma multiforme. The guidelines were published in the September issue of the Journal of Neuro-Oncology.
-
October 1, 2008
Stereotactic Radiation Improves Local Control but Not Survival in Stage I NSCLC
Researchers from Denmark have reported that the addition of stereotactic radiation therapy in early-stage inoperable non–small cell lung cancer (NSCLC) improves local disease control but does not improve overall survival. These results were recently presented at the 2008 annual American Society of Therapeutic Radiology and Oncology (ASTRO).
-
October 1, 2008
California restaurants will soon count calories
LOS ANGELES (Reuters) - Trend-setting, health-conscious California on Tuesday became the first U.S. state to require fast-food restaurant chains to list calories on their menus.
-
October 1, 2008
Survival Rates Improving in Childhood Hematologic Cancers
Researchers from Cornell University and Germany have reported that five- and 10-year survival rates in childhood hematalogic cancers have significantly improved in the United States since 1990. The details of this study were published in the September 17, 2008 issue of the Journal of the National Cancer Institute.
-
October 1, 2008
Danish study finds HRT does not raise heart attack
WASHINGTON (Reuters) - Women who take hormone replacement therapy to treat menopause symptoms do not have a higher than usual risk of heart attack, especially if they use a cream or skin patch or take "cyclic" hormone combinations, Danish researchers reported on Tuesday.
-
October 1, 2008
Vitamin C may blunt effect of chemotherapy
WASHINGTON (Reuters) - Vitamin C supplements may undercut the effectiveness of cancer drugs including Novartis' Gleevec (or Glivec), a U.S. study published on Wednesday showed.
-
October 1, 2008
Spit proteins could lead to oral cancer test: study
CHICAGO (Reuters) - A simple screen of proteins in human saliva was able to accurately detect a common type of oral cancer, a finding that may lead to a painless new diagnostic test, U.S. researchers said on Wednesday.
-
October 1, 2008
Genetic link found to colon cancer in study
CHICAGO (Reuters) - A gene related to a hormone secreted by the body's fat cells may lower the risk of colon cancer, a discovery that could reassure people with a family history of the disease, researchers said on Tuesday.
-
September 30, 2008
Narcotic patch effective for severe cancer pain
NEW YORK (Reuters Health) - A patch delivering buprenorphine, a potent narcotic painkiller, appears to be effective and safe for patients with severe cancer-related pain, European investigators report.